RVTY · News · 20260809N
Guidance / Outlook
REVVITY, INC. · 2026-08-09 · Importance 47 · Surprise 60 · In source text
Revvity raised its full-year outlook following stronger-than-expected second-quarter results. Management attributed the improved outlook to robust Diagnostics performance and increasing demand from pharmaceutical and biotechnology customers. The company also reported improving order activity in Life Sciences, particularly for AI-enabled drug-discovery tools, although the digest does not quantify the revised full-year revenue or earnings targets.
Key facts
- Revvity raised its full-year outlook following its second-quarter results. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | probable | — | Revvity raised its full-year outlook following its second-quarter results. |